Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2012, Article ID 616930, 2 pages
Case Report

Levothyroxine and Prednisone Causing Generalized Weakness in a Middle-Aged Man

1Departement of Internal Medicine, UT Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
2Division of Nephrology, Dallas VA Medical Center, 4500 S Lancaster Road, Dallas, TX 75216, USA

Received 10 September 2012; Accepted 8 October 2012

Academic Editors: M. Demura and L. Mastrandrea

Copyright © 2012 Andrew Word et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. T. C. Ko, C. C. Chow, V. T. F. Yeung, H. H. L. Chan, J. K. Y. Li, and C. S. Cockram, “Thyrotoxic periodic paralysis in a Chinese population,” Quarterly Journal of Medicine, vol. 89, no. 6, pp. 463–468, 1996. View at Google Scholar · View at Scopus
  2. A. W. C. Kung, “Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 7, pp. 2490–2495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Soonthornpun, W. Setasuban, and A. Thamprasit, “Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP),” Clinical Endocrinology, vol. 70, no. 5, pp. 794–797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Liu, L. E. Braverman, and A. Malabanan, “Thyrotoxic periodic paralysis in a hispanic man after the administration of prednisone,” Endocrine Practice, vol. 12, no. 4, pp. 427–431, 2006. View at Google Scholar · View at Scopus
  5. L. Wartofsky, “Levothyroxine: therapeutic use and regulatory issues related to bioequivalence,” Expert Opinion on Pharmacotherapy, vol. 3, no. 6, pp. 727–732, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. B. J. Dong, W. W. Hauck, J. G. Gambertoglio et al., “Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism,” Journal of the American Medical Association, vol. 277, no. 15, pp. 1205–1213, 1997. View at Google Scholar · View at Scopus
  7. Association of Clinical Endocrinologists, “AACE, TES, and ATA joint position statement on the use and interchangeability of thyroxine products 2008,” https:// .